AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Revzox 40mg Injection

Prescription Icon
Prescription Required

Marketer

Aarvi Drugs

Salt Composition

Piroxicam (40mg)

Overview Revzox 40mg Injection

Injex 40mg is an analgesic medication indicated for moderate to severe pain management. It effectively addresses pain and inflammation associated with musculoskeletal conditions, particularly when oral administration is impractical. Administration should always be performed by a qualified healthcare provider; self-injection is strictly prohibited. Dosage and treatment length are determined by individual response and the underlying condition, continuing until medically discontinued. Common adverse reactions may include injection site discomfort (pain, erythema, edema), nausea, abdominal pain, dyspepsia, diarrhea, cephalalgia, and vertigo. Persistent or worsening side effects necessitate immediate medical attention; management strategies may be implemented to mitigate these effects. Prior to treatment, disclose any history of peptic ulcers, cardiovascular disease, hypertension, or hepatic/renal impairment. Complete disclosure of all concurrent medications is crucial due to potential interactions. This medication is contraindicated during pregnancy and lactation; consultation with a physician is mandatory before use in these instances. Prolonged therapy may necessitate regular monitoring of renal and hepatic function, along with key blood parameters.

Uses of Revzox 40mg Injection

Analgesia

Major Benefits of Revzox 40mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Revzox 40mg Injection:

  • Injection site reactions (pain, swelling, redness)
  • Vomiting
  • Stomach pain
  • Nausea
  • Headache
  • Dizziness

How to use Revzox 40mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Revzox 40mg Injection works:

Revzox 40mg Injection, a non-steroidal anti-inflammatory drug, inhibits the production of inflammatory mediators, thus alleviating pain and swelling.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Use of Revzox 40mg Injection with alcohol requires careful consideration. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Revzox 40mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Employing Revzox 40mg Injection while breastfeeding is likely inadvisable. Available human data indicate potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Administering Revzox 40mg Injection can lead to drowsiness, visual disturbances, and dizziness. Driving should be avoided if these effects are experienced.

KidneyKidneyCAUTION

The administration of Revzox 40mg Injection requires careful consideration in individuals with advanced renal impairment. Dosage modification of Revzox 40mg Injection might be necessary. Physician consultation is advised.

LiverLiverCAUTION

Administering Revzox 40mg Injection to individuals with hepatic impairment requires careful consideration. Dosage modification of Revzox 40mg Injection might be necessary. Physician consultation is advised.

What if you forget to take Revzox 40mg Injection :

Omit a Revzox 40mg Injection? Seek your physician's advice.

Facts to Know About Revzox 40mg Injection

LabelValue
Type of Compound Esters of enolic acids
Potential for Dependence None.
Medication Classification Pain relievers

FAQs on Revzox 40mg Injection

Revzox 40mg Injection and diclofenac are analgesics. Piroxicam, the active ingredient in Revzox 40mg Injection, broadly inhibits cyclooxygenase (COX), an enzyme crucial in pain and inflammation. Diclofenac, conversely, exhibits greater selectivity for the COX-2 enzyme. This preferential action of diclofenac is believed to reduce the incidence of adverse reactions relative to Revzox 40mg Injection.
Naproxen and Revzox 40mg Injection are analgesic medications, both non-selectively inhibiting cyclooxygenase, the enzyme mediating inflammation and pain sensation. Clinical trials indicate comparable efficacy between the two. Nevertheless, naproxen demonstrates a lower incidence of gastrointestinal adverse effects relative to Revzox 40mg Injection.
Revzox 40mg Injection and meloxicam are analgesics that non-selectively inhibit cyclooxygenase, an enzyme mediating inflammation and pain. Clinical trials indicate comparable efficacy between the two. Nevertheless, meloxicam demonstrates a lower incidence of acute gastrointestinal adverse events relative to Revzox 40mg Injection.
Revzox 40mg Injection and ketoprofen are both analgesics, non-selectively inhibiting cyclooxygenase—the enzyme mediating inflammation and pain. Clinical trials indicate superior efficacy and tolerability for topical ketoprofen gel relative to Revzox 40mg Injection.
Revzox 40mg Injection targets COX enzymes, which contribute to inflammation and pain, while Tramadol provides analgesic relief through a narcotic-like mechanism. Tramadol carries a risk of dependence.
Revzox 40mg Injection and nimesulide are analgesics. Revzox 40mg Injection, unlike nimesulide, broadly inhibits COX enzymes—enzymes crucial in pain and inflammation generation. Nimesulide's selective COX-2 inhibition aims to reduce adverse reactions compared to piroxicam. Its use is contraindicated in children under 12.
Chikungunya typically doesn't cause a decrease in platelet count. However, analgesics such as piroxicam may heighten the risk of bleeding. Therefore, avoid Revzox 40mg Injection or other pain relievers if you experience fever with joint pain. Seek medical advice before using Revzox 40mg Injection.
Revzox 40mg Injection and aspirin are distinct medications, despite both being classified as COX (cyclooxygenase) inhibitors. Both possess anti-inflammatory and analgesic properties.
Concurrent administration of Revzox 40mg Injection and dexamethasone is contraindicated due to their synergistic toxicity, resulting in a heightened risk of gastrointestinal ulceration.
Concurrent use of methocarbamol and Revzox 40mg Injection is considered safe, lacking documented significant adverse interactions. However, physician consultation is advisable prior to initiating either treatment.
Concurrent use of paracetamol and Revzox 40mg Injection is considered safe, with no documented major adverse interactions. However, physician consultation is advised prior to commencing either treatment.
Affirmative. Revzox 40mg Injection is classified as a non-steroidal anti-inflammatory medication.
The injectable medication Revzox, 40mg strength, contains sulfur. This medication may trigger severe side effects in susceptible patients, potentially including serious skin reactions such as Stevens-Johnson syndrome. Always disclose any allergies to your physician.
Revzox 40mg Injection does not prevent blood clotting; it is an analgesic. Patients with hemorrhagic conditions should not use this medication.
Revzox 40mg Injection does not relax muscles. It's an analgesic that targets the COX enzyme (cyclooxygenase), which mediates inflammation and pain.
Revzox 40mg Injection is a non-narcotic analgesic. Its mechanism of action involves inhibiting cyclooxygenase (COX), an enzyme crucial in inflammatory and pain processes, thereby reducing pain and inflammation.
Revzox 40mg Injection does not manage high blood pressure. Concurrent administration with antihypertensive drugs reduces their efficacy. Disclose any antihypertensive medication use to your physician prior to commencing Revzox 40mg Injection.
Concomitant administration of Revzox 40mg Injection and Losartan is contraindicated. The combined use diminishes the antihypertensive efficacy of Losartan, potentially resulting in treatment failure. Patients currently using antihypertensive drugs must disclose this information to their physician prior to commencing Revzox 40mg Injection.
Concurrent use of Revzox 40mg Injection and lisinopril is contraindicated. Piroxicam's interaction with lisinopril diminishes the latter's antihypertensive effect, potentially compromising blood pressure control. Disclose any antihypertensive medication use to your physician prior to commencing Revzox 40mg Injection therapy.
Affirmative. Concurrent administration of Revzox 40mg Injection and calcium channel blockers is permissible. Studies indicate NSAIDs diminish the efficacy of most antihypertensive medications, with calcium channel blockers representing an exception (White, 2007).
Tizanidine can be used concurrently with Revzox 40mg Injection. Piroxicam, an analgesic, and tizanidine, a skeletal muscle relaxant, are indicated for conditions such as back pain.
Affirmative. The 40mg Revzox Injection is compatible with beta-cyclodextrin. Studies indicate this combination accelerates piroxicam's efficacy and mitigates gastrointestinal adverse reactions.
Affirmative. Alternative treatments to Revzox 40mg Injection exist. Analgesic selection depends on the specific illness. Physician consultation is recommended prior to commencing piroxicam therapy or switching medications.
Piroxicam should not be used in patients with hypersensitivity, bleeding disorders, duodenal, gastric, or peptic ulcers, mouth sores, systemic lupus erythematosus, ulcerative colitis, upper gastrointestinal problems, late-stage pregnancy, heart conditions, liver dysfunction, or kidney dysfunction.
Revzox 40mg Injection does not treat allergies; it is an analgesic.
The injectable formulation of Revzox, 40mg, provides extended pain relief. While a single daily dose often suffices, individual responses vary, with the analgesic effects of piroxicam generally improving over several weeks of use.
Revzox 40mg Injection does not produce a euphoric effect. This medication is a non-opioid analgesic.
Revzox 40mg Injection lacks approval for managing dysmenorrhea. Clinical trials indicate that piroxicam demonstrates considerable efficacy in substantially reducing menstrual pain.
The drug Revzox, administered as a 40mg injection, lacks regulatory approval for migraine treatment. Clinical trials have demonstrated its efficacy in substantially reducing migraine pain in individuals without aura.
Affirmative. This medication may alleviate back pain. Nevertheless, a physician's consultation to determine the underlying cause of your back pain is crucial before commencing treatment. Avoid self-administering Revzox 40mg Injection, as the etiology of back pain varies individually.
Affirmative. Revzox 40mg Injection is suitable for managing acute gout. Clinical trials demonstrate significant efficacy of Revzox 40mg Injection in acute gout treatment.
Blood donation is permissible while using Revzox 40mg Injection. However, it's crucial to disclose your medication use to the attending physician prior to donation.
In diabetic individuals, the use of Revzox 40mg Injection requires strict medical supervision. Prolonged administration of this medication carries a significant risk of kidney damage. Given that diabetes is itself a risk factor for renal impairment, the addition of piroxicam (Revzox) substantially increases the likelihood of renal failure.
Individuals with impaired kidney function should avoid Revzox 40mg Injection. Prolonged use of nonsteroidal anti-inflammatory drugs (NSAIDs) is linked to kidney damage, including papillary necrosis.
Affirmative. Revzox 40mg injections have been associated with potentially severe cutaneous adverse reactions, including exfoliative dermatitis, Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN), the latter of which can be life-threatening. These serious reactions may develop unexpectedly. Report any skin rash, even if mild, to your physician and cease using the medication immediately.
Administration of Revzox 40mg Injection is contraindicated during pregnancy. Its use may result in premature closure of the ductus arteriosus, potentially causing fetal cardiac failure and infant mortality.
Revzox 40mg Injection is not suitable for patients with active peptic ulcers. This medication has been associated with the development of gastric ulcers and hemorrhage.
Individuals with asthma may experience heightened sensitivity to non-steroidal anti-inflammatory medications, such as aspirin, potentially triggering severe asthma episodes. Physician consultation is recommended prior to commencing treatment with these drugs.
Affirmative. Revzox 40mg injections may induce temporary infertility. Piroxicam's mechanism of action can potentially hinder or obstruct the release of ovarian follicles, a factor linked to reversible infertility in certain patients. Seek medical advice prior to commencing treatment with this drug.
Revzox 40mg Injection is contraindicated for concurrent use with diuretics. In certain individuals, Revzox 40mg Injection diminishes the sodium-excreting action of furosemide and thiazide diuretics. This effect is believed to result from suppressed renal prostaglandin production.
Concurrent administration of Revzox 40mg Injection and lithium is contraindicated. Revzox 40mg Injection elevates plasma lithium concentrations and diminishes renal lithium excretion. This effect stems from the nonsteroidal anti-inflammatory drug's (NSAID) inhibition of renal prostaglandin production. Physician consultation is mandatory prior to initiating this injection.
Concurrent use of Revzox 40mg Injection and warfarin is contraindicated due to a heightened risk of hemorrhage. Patients should disclose all current medications to their physician. Should co-administration be necessary, rigorous monitoring is essential.
Individuals using corticosteroids or anticoagulants face a heightened risk of developing gastric ulcers. Prolonged medication use, alcohol consumption, tobacco use, and advanced age are additional risk factors for ulcer formation.
Individuals experiencing asthma, urticaria, or other allergic responses to aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), or analgesics, either immediately preceding or following coronary artery bypass grafting.
Gastrointestinal distress, and in infrequent cases, severe gastrointestinal adverse reactions including peptic ulcers and hemorrhage; severe dermatological reactions including exfoliative dermatitis, Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis; hepatic insufficiency; and kidney injury.
Revzox 40mg Injection
20
MRP 24
16% off